NeoGenomics Completes Acquisition of Genoptix
NeoGenomics (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services, announced today that it has completed the acquisition of the parent...
Oxford Immunotec Announces Regulatory Acceptance of T-Cell Select in China
Oxford Immunotec Global (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced regulatory acceptance of the T-Cell Selectkit by the China...
Myriad Validates Polygenic Score to Predict Breast Cancer Risk
Myriad Genetics (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced results from an important study to validate the...
TATAA Biocenter Expands Its Next-Generation Sequencing Offerings with HTG Molecular Diagnostics’ Unique HTG EdgeSeq System
TATAA Biocenter, Europe’s leading provider of genomic services, and HTG Molecular Diagnostics (Nasdaq:HTGM), a provider of instruments, reagents, and services...
Histogenics and FDA Continue to Discuss NeoCart Phase 3 Clinical Trial Data and Potential Regulatory Pathway
Histogenics (Nasdaq:HSGX), a leader in the development of restorative cell therapies that may offer rapid-onset pain relief and restored function,...
Medline and Biomerica sign agreement for distribution of Biomerica’s colorectal screening test
Biomerica (Nasdaq:BMRA) announced that is has signed a three year agreement with Medline Industries for the distribution of Biomerica’s EZ...
Pluristem to Present First Cohort Data from PLX-R18 Hematological Study at ASH Annual Meeting
Pluristem Therapeutics (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing novel placenta-based cell therapy products, today announced that the company will...